Growth Metrics

Palisade Bio (PALI) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 Palisade Bio 439.25 Mn 309.68 Mn - -61.98%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -61.98%
Dec 31, 2025 -37.37%
Sep 30, 2025 12.82%
Jun 30, 2025 7.35%
Mar 31, 2025 15.93%
Dec 31, 2024 5.66%
Sep 30, 2024 -5.76%
Jun 30, 2024 49.91%
Mar 31, 2024 -0.12%
Dec 31, 2023 2.77%
Sep 30, 2023 -27.28%
Jun 30, 2023 -25.15%
Mar 31, 2023 -8.50%
Dec 31, 2022 -21.93%
Sep 30, 2022 -27.91%
Jun 30, 2022 -23.30%
Mar 31, 2022 -16.98%
Dec 31, 2021 -31.22%
Sep 30, 2021 -13.76%
Jun 30, 2021 -155.71%
Mar 31, 2021 -16.20%
Dec 31, 2020 -15.07%
Sep 30, 2020 10.61%
Jun 30, 2020 24.14%
Mar 31, 2020 23.08%
Dec 31, 2019 28.56%
Sep 30, 2019 25.67%
Jun 30, 2019 22.78%
Mar 31, 2019 28.36%
Dec 31, 2018 27.97%
Sep 30, 2018 28.43%
Jun 30, 2018 28.30%
Mar 31, 2018 22.71%
Dec 31, 2017 23.60%
Sep 30, 2017 16.74%
Jun 30, 2017 -2.74%
Mar 31, 2017 7.99%
Dec 31, 2016 -22.14%
Sep 30, 2016 -8.14%
Jun 30, 2016 -4.24%
Mar 31, 2016 -31.14%
Dec 31, 2015 -20.70%
Sep 30, 2015 -29.80%
Jun 30, 2015 -31.78%
Mar 31, 2015 -27.20%
Dec 31, 2014 -25.54%
Sep 30, 2014 -11.53%
Jun 30, 2014 -2.17%
Mar 31, 2014 -16.70%
Dec 31, 2013 -28.17%
Sep 30, 2013 -1.33%
Jun 30, 2013 4.40%